Acinetobacter baumannii genome sequence determined

Italy - The genome sequence of Acinetobacter baumannii has been determined by scientists at the Istituto di Tecnologie Biomediche, the Dipartimento di Malattie Infettive at the Istituto Superiore della Sanità and the Dipartimento di Biologia at Roma Tre University. In Italy alone this antibiotic resistant pathogen causes 4,500 to 7,000 deaths annually.

Genome sequencing is the foundation for rapid diagnosis and targeted therapy approaches, said project manager Gianluca de Bellis. ‘Sequencing was made possible by a further improved technique which can generate more than 100 million DNA bases within a few hours. This translates into a significant time and cost advantage over the previous methods.’ Using this sequencing method the Italian scientists hope to identify new substances for the development of new antibiotics. The phenomenon of antibiotic resistance will be examined from a basic and applied research angle.
This genetic sequence is available free, via www.itb.cnr.it/genome-project.

01.07.2008

More on the subject:

Related articles

Photo

News • Millifluidic nanogenerator

Blood-powered lab-on-a-chip to enhance disease monitoring

Researchers are proposing a new device that uses blood to generate electricity and measure its conductivity, opening doors to medical care in any location.

Photo

News • Integration of microanalysis chips

Establishing microfluidic control technology for blood testing devices

A research group established a microfluidic control technology that can be applied to small blood testing devices and consequently developed a novel integrated immunoassay device.

Photo

News • Urine-based diagnostics

New prostate cancer test to help avoid unnecessary biopsies

US researchers have developed and validated a new urine-based test for prostate cancer, which was shown to meaningfully reduce unnecessary prostate biopsies while providing highly accurate detection.

Related products

Subscribe to Newsletter